Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) traded at $17.45 at close of the session on Tuesday, April 01 and made a downward move of -2.38% on its previous day’s price.
Looking at the stock we see that its previous close was $17.88 and the beta (5Y monthly) reads 2.238 with the day’s price range being $16.5055 – $19.465. In terms of its 52-week price range, TNXP has a high of $672.00 and a low of $6.76. The company’s stock has gained about 136.45% over that past 30 days.
Tonix Pharmaceuticals Holding Corp has a market cap of $112.29 million and is expected to release its quarterly earnings report on 2025-Mar-17.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 2.6M, with a low of 2.6M and a high of 2.6M. The median projection represents growth squeezing down to 4.75% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 11.1M, or 9.97% up from figures reported last year.
On the other hand, looking at the outlook for the TNXP stock, short term indicators assign the stock an average of 100% Sell, while medium term indicators assign it an average of 100% Sell.
Based on estimates by 5 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 1 have rated the Tonix Pharmaceuticals Holding Corp (TNXP) stock as a Hold, while 4 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 0 suggest the stock as a Sell. The stock has an overall rating of Buy and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is -6.55% off its SMA20 and -7.10% from its 50-day simple moving average. The RSI (14) is pointing at 47.53 while the volatility over the past week is 23.16% and jumps to 24.33% over the past one month. The beta value is 1.51, while the average true range (ATR) is currently pointing at 4.41.
Coming back to Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP), we note that the average 3-month trading volume was 1.69 million, while that of the preceding 10-day period stands at 2.36 million. Current shares outstanding are 6.43 million.
The insiders hold 0.00% of the company’s shares while institutions hold 2.48%. The data shows that short shares as of 2025-03-14, stood at 0.88 million at a short ratio of 0.56. This represents a 1365.00 short interest in shares outstanding on 2025-03-14. Shares short rose in March from the previous month at 0.33 million. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -47.09% down in year-to-date price movement.
